PE-Backed Luye Pharma Plans $750M HK IPO

This Data Is Locked!

This area is available only to Subscribers.

Yantai, Shandong Province-based Chinese drug-maker Luye Pharma Group, which is backed by Chinese private equity firms, is planning an IPO in Hong Kong during the... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?